Trulieve Cannabis (TRLV) Payables (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Payables for 7 consecutive years, with $174.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables rose 84.18% year-over-year to $174.3 million; the TTM figure through Mar 2026 stood at $174.3 million (up 84.18% YoY), while the FY2025 annual figure was $178.8 million, up 83.46% from the prior year.
• Payables came in at $174.3 million for Q1 2026 at Trulieve Cannabis, down from $178.8 million in the prior quarter.
• The five-year high for Payables was $214.0 million in Q3 2024, with the low at $24.1 million in Q1 2022.
• Average Payables over 5 years is $136.0 million, with a median of $102.3 million recorded in 2023.
• Across the five-year window, Payables jumped 922.63% in 2022 and tumbled 53.53% in 2025, its largest moves.
• Year by year, Payables stood at $190.6 million in 2022, then grew by 7.54% to $204.9 million in 2023, then plunged by 52.45% to $97.4 million in 2024, then soared by 83.46% to $178.8 million in 2025, then slipped by 2.52% to $174.3 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $174.3 million, $178.8 million, and $194.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.